Company intelligence / Profile preview

Saffron Tech

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Saffron Tech has demonstrated commercial-scale indoor saffron cultivation using proprietary CEA, with 44x yield improvement over traditional farming. Its saffron extracts are supplied to the supplement and cosmetic sectors, with clinical results mainly limited to in vitro (compound-level) and market/ingredient-level health claims; clinical trials of the extracts are not explicitly listed.

Therapeutic areas: PsychiatryImmunologyDermatologyOther
Modalities: Botanical extractFood supplement ingredientNatural product
Industry: Agriculture & AgTech

Partnerships

Licensing agreements with vertical farmsunspecified B2B partnerships with supplement/cosmetic companies

Beyond the preview

Go deeper on Saffron Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saffron Tech.

Explore the full profile